These experimental treatments include a weight loss pill, orforglipron
After many years of development, Titan revealed the first functional prototype of Sport in March 2016 at a meeting held by the Society of American Gastrointestinal and Endoscopic Surgeons
1 To better understand the potential relationship between GLP-1 medications and mental health diagnoses after starting the medications, we studied 3,081,254 diabetic patients and 929,174 non-diabetic patients
Novo Nordisk Inc and Novo Nordisk A/S v Viatris Inc and Mylan Pharmaceuticals, 1:23-cv-00101 and Novo Nordisk Inc and Novo Nordisk A/S v Sun Pharmaceutical Industries Ltd and Sun Pharmaceutical Industries, Inc, 1:23-cv-01459 17 The drop in patent filings observed in 2023 may reflect several factors
This property alone provides a powerful defence against aging and disease
What is the dark side of GLP-1